 |
市场调查报告书
商品编码
1136953
Budesonide吸入器市场:各产品类型，用量，强度，各流通管道，各地区- 规模，占有率，展望，机会分析，2022年～2030年Budesonide Inhaler Market, by Product Type, by Dosage, by Strength, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 |
||||||
价格
简介目录
市场动态
由于哮喘发病率和患病率的增加，预计全球对布地奈德吸入器的需求将在预测期内出现显着增长。
本调查的主要特征
- 本报告提供以2021年为基准年的预测期间（2022-2030 年）之全球Budesonide吸入器市场的市场规模和復合年增长率（CAGR %）相关的详细分析。
- 并阐明不同部门市场的潜在收入机会，说明该市场具有魅力的投资主张矩阵。
- 同时并提供市场推动因素和限制、机会、新产品发布或批准、市场趋势、区域前景和主要参与者采用的竞争战略等重要考察。
- 并基于企业亮点，各类型投资组合、主要焦点、财务业绩和市场策略等参数，介绍全球Budesonide吸入器市场的主要参与者之企业简介。
- 藉由该报告提供的洞察，将能帮助营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
- 全球Budesonide吸入器市场报告配合该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
- 利益相关者可以透过全球Budesonide吸入器市场用于分析的各种战略矩阵来帮助他们更容易做下决策。
目录
第1章 调查目的与前提条件
- 调查目的
- 前提条件
- 简称的说明
第2章 市场展望
- 报告内容
- 市场定义和范围
- 摘要整理
- 市场概述:各产品类型
- 市场概述:各剂量
- 市场概述:各强度
- 市场概述:各流通管道
- 市场概述:各地区
- 连贯机遇地图(COM)
第3章 市场动态，法规，趋势分析
- 市场动态
- 促进因素
- 阻碍因素
- 市场机会
- 影响分析
- 市场趋势
- 主要的发展情形
- 法规情形
- 产品回收
- 流行病学分析
- 技术概要
- PEST分析
- 波特的五力分析
第4章 Budesonide吸入器的全球市场:冠状病毒(COVID-19)疫情的影响
- 整体影响
- COVID-19对市场的影响
第5章 Budesonide吸入器的全球市场:各产品类型，2017年～2030年
- 吸入器
- 喷雾器
第6章 Budesonide吸入器的全球市场:各用法用量，2017年～2030年
- 气雾剂
- 干粉
- 悬浮液
- 喷雾
第7章 Budesonide吸入器的全球市场，强度，2017年～2030年
- 25mg
- 5mg
- 0mg
第8章 Budesonide吸入器的全球市场:各流通管道，2017年～2030年
- 医院内药局
- 零售药局
- 线上药局
第9章 Budesonide吸入器的全球市场:各地区，2017年～2030年
- 市场占有率分析，各地区，2022年及2030年(%)
- 与前一年同期比较成长率分析(各地区)，2017年～2030年
- 各地区趋势
- 北美
- 市场规模及预测，YoY成长率，各产品类型，2017年～2030年
- 用量市场规模及预测，与前一年同期比较成长率，2017年-2030年
- 强度的市场规模及预测，与前一年同期比较成长率，2017年～2030年
- 市场规模·预测及与前一年同期比较成长率:各流通管道，2017年-2030年
- 市场规模及预测，与前一年同期比较成长率，各国，2017年～2030年
- 美国
- 加拿大
- 南美
- 各产品类型市场规模及预测，YoY成长率，2017年～2030年
- 用量市场规模及预测，与前一年同期比较成长率，2017年～2030年
- 强度的市场规模及预测，与前一年同期比较成长率，2017年-2030年
- 市场规模·预测及与前一年同期比较成长率:各流通管道，2017年-2030年
- 市场规模及预测，与前一年同期比较成长率，各国，2017年～2030年
- 巴西
- 墨西哥
- 阿根廷
- 其他的南美地区
- 欧洲
- 各产品类型市场规模，预测，及YoY成长率，2017年～2030年
- 用量市场规模及预测，与前一年同期比较成长率，2017年～2030年
- 强度的市场规模及预测，与前一年同期比较成长率，2017年-2030年
- 市场规模·预测及与前一年同期比较成长率:各流通管道，2017年-2030年
- 市场规模及预测，与前一年同期比较成长率，各国，2017年～2030年
- 英国
- 德国
- 义大利
- 法国
- 西班牙
- 俄罗斯
- 其他欧洲
- 亚太地区
- 各产品类型市场规模，预测，及YoY成长率，2017年～2030年
- 用量市场规模及预测，与前一年同期比较成长率，2017年～2030年
- 强度的市场规模及预测，与前一年同期比较成长率，2017年-2030年
- 市场规模·预测及与前一年同期比较成长率:各流通管道，2017年-2030年
- 各国市场规模及预测，与前一年同期比较成长率，2017年～2030年
- 中国
- 印度
- 日本
- ASEAN
- 澳洲
- 韩国
- 其他亚太地区
- 中东地区
- 各产品类型市场规模，预测，及YoY成长率，2017年～2030年
- 用量市场规模及预测，与前一年同期比较成长率，2017年～2030年
- 强度的市场规模及预测，与前一年同期比较成长率，2017年～2030年
- 市场规模·预测及与前一年同期比较成长率:各流通管道，2017年-2030年
- 市场规模及预测，与前一年同期比较成长率，各国，2017年～2030年
- GCC
- 以色列
- 其他中东地区
- 非洲
- 各产品类型市场规模·预测及YoY成长率:2017年～2030年
- 用量市场规模及预测，与前一年同期比较成长率，2017年～2030年
- 强度的市场规模及预测，与前一年同期比较成长率，2017年～2030年
- 市场规模·预测及与前一年同期比较成长率:各流通管道，2017年-2030年
- 市场规模及预测，与前一年同期比较成长率，各国，2017年～2030年
- 北非
- 中非
- 南非
第10章 竞争情形
- 热图分析
- 企业简介
- Pfizer, Inc.
- Cipla Limited
- Lupin Limited
- Cosmo Pharmaceuticals
- Takeda Pharmaceutical Company Ltd
- Manus Aktteva Biopharma LLP
- Abbott Laboratories
- Lunan Better Pharmaceutical
- Novartis International AG(Sandoz)
- Mylan N.V.
- Skyepharma
- AstraZeneca Plc.
- Chiesi Farmaceutici S.p.A.
- Orion Corporation
- Santarus Inc.
- Synmosa Biopharma Corporation
- Shanghai Sine Pharmaceutical Laboratories Co. Ltd.
第11章 章节
- 参考文献
- 调查手法的介绍
- 关于出版社
简介目录
Product Code: CMI2551
Budesonide is an artificial glucocorticoid steroid related to the naturally-occurring hormone, cortisol or hydrocortisone, which is produced in the adrenal glands. It is used for treating asthma. Budesonide is sold under the brand name Pulmicort. Each budesonide inhaler is designed to provide 60 to 120 inhalations depending on the device. Increasing air population is expected to lead to high prevalence of asthma worldwide. For instance, on May 11, 2022, according to the World Health Organization (WHO), Asthma is a major non-communicable disease (NCD), affecting both children and adults, and is the most common chronic disease among children globally. Asthma affected an estimated 262 million people in 2019 and caused 455 000 deaths globally. Most asthma-related deaths occur in low- and lower-middle-income countries such as India and Bangladesh, where under-diagnosis and under-treatment is a challenge.
Market Dynamics
The global demand for budesonide inhaler is expected to witness substantial growth over the forecast period, owing to increasing incidences and prevalence of asthma. According to the Global Asthma Report 2018, asthma causes around 1,000 deaths every day and affects as many as 339 million people worldwide.
Increasing product launch by the key market player in expected to boost the growth of global budesonide inhaler market over the forecast period. For instance, in November 2019, Lupin, Pharmaceutical Company, announced the launch of device to track usage pattern of metered-dose inhalers (MDI) by patients suffering from chronic respiratory diseases. The device helped the patients track their metered-dose inhalers (MDI) usage and facilitate improved adherence to therapy. The inhalers are the treatment option for managing chronic respiratory diseases such as Asthma and Chronic Obstructive Pulmonary Disease (COPD).
Key features of the study:
- This report provides an in-depth analysis of the global budesonide inhaler market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2022 - 2030, considering 2021 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
- It profiles key players in the global budesonide inhaler market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
- Key players covered as a part of this study include, Pfizer Inc., Cipla Limited, Lupin Limited, Cosmo Pharmaceuticals, Takeda Pharmaceutical Company Ltd., Manus Aktteva Biopharma LLP, Abbott Laboratories, Lunan Better Pharmaceutical, Novartis International AG (Sandoz), Mylan N.V., Skyepharma, AstraZeneca Plc., Chiesi Farmaceutici S.p.A, Orion Corporation, Santarus Inc., Synmosa Biopharma Corporation, and Shanghai Sine Pharmaceutical Laboratories Co. Ltd.
- Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
- The global budesonide inhaler market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, suppliers, research and consulting firms, new entrants, and financial analysts
- Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global budesonide inhaler market.
Detailed Segmentation:
- Global Budesonide Inhaler Market, By Product type:
- Inhalants
- Nebulizer
- Global Budesonide Inhaler Market, By Dosage:
- Aerosols
- Dry Powder
- Suspension
- Spray
- Global Budesonide Inhaler Market, By Strength:
- 25 mg
- 5 mg
- 0 mg
- Global Budesonide Inhaler Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Budesonide Inhaler Market, By Region:
- North America
- By Country
- U.S.
- Canada
- Europe
- By Country
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia Pacific
- By Country
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- Others By Country/Region
- South Africa
- Central Africa
- North Africa
- North America
- Company Profiles
- Pfizer Inc.*
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Cipla Limited
- Lupin Limited
- Cosmo Pharmaceuticals
- Takeda Pharmaceutical Company Ltd.
- Manus Aktteva Biopharma LLP
- Abbott Laboratories
- Lunan Better Pharmaceutical
- Novartis International AG (Sandoz)
- Mylan N.V.
- Skyepharma,
- AstraZeneca Plc.
- Chiesi Farmaceutici S.p.A.
- Orion Corporation
- Santarus Inc.
- Synmosa Biopharma Corporation
- Shanghai Sine Pharmaceutical Laboratories Co. Ltd.
- Pfizer Inc.*
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Dosage
- Market Snapshot, By Strength
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Landscape
- Product Recall
- Epidemiology Analysis
- Technology Overview
- PEST Analysis
- Porter's Five Forces Model
4. Global Budesonide Inhaler Market - Impact of Coronavirus (Covid-19) Pandemic
- Overall Impact
- COVID-19 Impact on the market
5. Global Budesonide Inhaler Market, By Product Type, 2017 - 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Inhalants
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Nebulizers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
6. Global Budesonide Inhaler Market, By Dosage,2017 - 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017- 2030
- Segment Trends
- Aerosols
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Dry Powder
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Suspension
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Spray
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
7. Global Budesonide Inhaler Market, By Strength,2017 - 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017- 2030
- Segment Trends
- 25mg
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- 5mg
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- 0mg
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
8. Global Budesonide Inhaler Market, By Distribution Channel, 2017 - 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million )
9. Global Budesonide Inhaler Market,, By Region, 2017 - 2030, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Strength, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million )
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Strength, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million )
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Strength, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million )
- UK
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Strength, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million )
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Strength, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million )
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Strength, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million )
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Heat Map Analysis
- Company Profile
- Pfizer, Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Cipla Limited
- Lupin Limited
- Cosmo Pharmaceuticals
- Takeda Pharmaceutical Company Ltd
- Manus Aktteva Biopharma LLP
- Abbott Laboratories
- Lunan Better Pharmaceutical
- Novartis International AG (Sandoz)
- Mylan N.V.
- Skyepharma
- AstraZeneca Plc.
- Chiesi Farmaceutici S.p.A.
- Orion Corporation
- Santarus Inc.
- Synmosa Biopharma Corporation
- Shanghai Sine Pharmaceutical Laboratories Co. Ltd.
- Analyst Views
11. Section
- References
- Research Methodology
- About Us
